Regenerative medicine is likely game changer for cardiovascular disease28Dec
NEW ORLEANS – Regenerative medicine has much to offer the cardiovascular field, although there is still a way to go before it is ready for routine clinical application, according to Andre Terzic, MD, PhD, director of the Mayo Clinic Center for Regenerative Medicine and a professor in Cardiovascular Diseases Research at the Mayo Clinic, in Rochester, Minn.
Trials testing a variety of stem cell approaches in patients with conditions such as acute myocardial infarction, peripheral arterial disease, and dilated cardiomyopathy are providing important lessons about this novel strategy and showing its potential, he said in a state of the science talk at the American Heart Association scientific sessions.
Impact on therapeutic approaches and goals
“This is a true paradigm shift in how we are approaching patients from a more traditional fighting of disease, whether it’s in the vascular or cardiac arena, to ultimately really where regenerative medicine is driving: rebuilding vascular and heart health,” Dr. Terzic maintained.
Moreover, regenerative medicine is expanding the goals of care. “It’s not necessarily just focused on repair, but there is this whole continuum of prevention, protection, and repair, in the context of the aging patient and in the context of matching health span with life span in this increasingly vulnerable population,” he elaborated.
Leaders in the field have put forth an associated value proposition, estimating that a decade from now, regenerative medicine will account for about 10% of all health care delivered globally, according to Dr. Terzic. And research presented at the meeting is a major step in that direction.
The potential applications in cardiovascular medicine are…
If you would like more information or would like us to
contact you please fill in the form below and we will respond promptly.
11503 NW Military Hwy, Suite 307
San Antonio, TX 78231
P: (877) 781-4406
F: (877) 292-9353